NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+24.44%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.78B
AUM Growth
+$1.78B
(-11%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-9.01%
Top 10 Holdings %
Top 10 Hldgs %
64.26%
Holding
62
New
5
Increased
1
Reduced
29
Closed
5
Top Buys
Top Sells
| 1 |
Arcellx
ACLX
|
$62.1M |
| 2 |
IonQ
IONQ
|
$40.5M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$32.5M |
| 4 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$29.1M |
| 5 |
IVA
Inventiva
IVA
|
$19.7M |
Sector Composition
| 1 | Healthcare | 71.35% |
| 2 | Consumer Staples | 10.55% |
| 3 | Technology | 10.5% |
| 4 | Industrials | 7.01% |
| 5 | Communication Services | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Coursera
COUR
$1.88B
| $188M | 10.55% | 15,867,769 | – | – |
|
|
2
Arcellx
ACLX
$3.85B
| $147M | 8.26% | 4,745,262 -2,005,002 | -30% | -$62.1M |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $146M | 8.2% | 5,584,753 | – | – |
|
4
Rhythm Pharmaceuticals
RYTM
$6.85B
| $143M | 8.03% | 4,909,956 -2,350 | -0% | -$68.4K |
|
5
NeueHealth
NEUE
$59.2M
| $142M | 7.97% | 218,153,623 -58,503 | -0% | -$38K |
|
6
Cloudflare
NET
$72.7B
| $84.7M | 4.76% | 1,873,823 -3,687 | -0.2% | -$167K |
|
7
Mirum Pharmaceuticals
MIRM
$3.71B
| $81.6M | 4.59% | 4,186,243 -1,558 | -0% | -$30.4K |
|
|
ZFOX
8
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $81M | 4.55% | 18,068,513 -22,348 | -0.1% | -$100K |
|
|
OYST
9
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $66.2M | 3.72% | 5,925,287 | – | – |
|
10
CRISPR Therapeutics
CRSP
$4.71B
| $64.5M | 3.63% | 1,587,854 -2,148 | -0.1% | -$87.3K |
|
11
Monte Rosa Therapeutics
GLUE
$296M
| $58.5M | 3.29% | 7,692,298 -10,907 | -0.1% | -$83K |
|
|
ALLK
12
DELISTED
Allakos
ALLK
| $51.8M | 2.91% | 6,147,260 -1,444 | -0% | -$12.2K |
|
|
13
IonQ
IONQ
$12.7B
| $50.4M | 2.83% | 14,614,829 -11,735,238 | -45% | -$40.5M |
|
14
CVRx
CVRX
$205M
| $43.5M | 2.44% | 2,370,542 -316 | -0% | -$5.8K |
|
15
Geron
GERN
$893M
| $39.5M | 2.22% | 16,318,681 | – | – |
|
16
Savara
SVRA
$567M
| $37.4M | 2.1% | 24,137,931 | – | – |
|
|
CBIO
17
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $27.2M | 1.53% | 8,967,706 -121,335 | -1% | -$368K |
|
|
ADAP
18
Adaptimmune Therapeutics
ADAP
$15.6M
| $24.9M | 1.4% | 17,079,779 -2,833 | -0% | -$4.14K |
|
19
NextNav
NN
$2.37B
| $24M | 1.35% | 8,189,156 | – | – |
|
|
BGRY
20
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $23.1M | 1.3% | 38,183,023 -43,598 | -0.1% | -$26.3K |
|
|
CTIC
21
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $22.2M | 1.24% | 3,685,683 | – | – |
|
22
Trevi Therapeutics
TRVI
$883M
| $22M | 1.23% | 11,373,174 | – | – |
|
23
Nkarta
NKTX
$151M
| $21.4M | 1.2% | 3,568,781 -2,859 | -0.1% | -$17.1K |
|
|
DM
24
DELISTED
Desktop Metal, Inc.
DM
| $19.6M | 1.1% | 14,398,927 -8,667 | -0.1% | -$11.8K |
|
25
Celcuity
CELC
$2.17B
| $17.5M | 0.98% | +1,250,001 | New | +$17.5M |
|